153 related articles for article (PubMed ID: 5485151)
1. Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with L-DOPA.
Boullin DJ; O'Brien RA
Br J Pharmacol; 1970 Aug; 39(4):779-88. PubMed ID: 5485151
[TBL] [Abstract][Full Text] [Related]
2. Uptake of dopamine by platelets in vivo.
Boullin DJ; McMahon EM; O'Brien RA
Br J Pharmacol; 1970 Nov; 40(3):522-3. PubMed ID: 5497799
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.
Gordon JL; Olverman HJ
Br J Pharmacol; 1978 Feb; 62(2):219-26. PubMed ID: 623937
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of quinidine by human blood platelets: effects on platelet ultrastructure and 5-hydroxytryptamine.
Boullin DJ; O'Brien RA
Br J Pharmacol; 1971 May; 42(1):114-26. PubMed ID: 5580696
[TBL] [Abstract][Full Text] [Related]
5. Simple gas chromatographic analysis of plasma dopa and dopamine.
Mizuno Y
Clin Chim Acta; 1977 Jan; 74(1):11-9. PubMed ID: 832410
[TBL] [Abstract][Full Text] [Related]
6. Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.
Weiss HJ; Tschopp TB; Rogers J; Brand H
J Clin Invest; 1974 Aug; 54(2):421-33. PubMed ID: 4847252
[TBL] [Abstract][Full Text] [Related]
7. Platelets and biogenic amines. 1. Platelets are poor investigative models for dopamine re-uptake.
Malmgren R
Psychopharmacology (Berl); 1984; 84(4):480-5. PubMed ID: 6441948
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome.
Boullin DJ; O'Brien RA
J Physiol; 1971 Jan; 212(2):287-97. PubMed ID: 4251289
[TBL] [Abstract][Full Text] [Related]
9. Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease.
Blandini F; Nappi G; Fancellu R; Mangiagalli A; Samuele A; Riboldazzi G; Calandrella D; Pacchetti C; Bono G; Martignoni E
J Neural Transm (Vienna); 2003 Aug; 110(8):911-22. PubMed ID: 12898346
[TBL] [Abstract][Full Text] [Related]
10. Serotonin content of platelet enriched plasma in Parkinson patients prior and during treatment with L-3,4-dihydroxyphenylalanine (L-DOPA).
Yamaguchi K; Tomasi L; Cote LJ; Barrett R; Yahr MD
Biochem Med; 1972 Jun; 6(3):210-5. PubMed ID: 5041890
[No Abstract] [Full Text] [Related]
11. Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease.
Barbeau A; Campanella G; Butterworth RF; Yamada K
Neurology; 1975 Jan; 25(1):1-9. PubMed ID: 234181
[TBL] [Abstract][Full Text] [Related]
12. Uptake of dopamine and 5-hydroxytryptamine by platelets of patients with Parkinsonism.
Aminoff MJ; Ehsanullah RS; Turner P
J Neurol Neurosurg Psychiatry; 1978 Jul; 41(7):589-92. PubMed ID: 690635
[TBL] [Abstract][Full Text] [Related]
13. Dopamine uptake in platelets: two different low-affinity, saturable mechanisms.
Lingjaerde O; Kildemo O
Agents Actions; 1981 Jul; 11(4):410-6. PubMed ID: 7282492
[TBL] [Abstract][Full Text] [Related]
14. The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets.
BORN GV; INGRAM GI; STACEY RS
Br J Pharmacol Chemother; 1958 Mar; 13(1):62-4. PubMed ID: 13523136
[TBL] [Abstract][Full Text] [Related]
15. [3H] dopamine uptake by platelet storage granules in Parkinson's disease.
Rabey JM; Shabtai H; Graff E; Oberman Z
Life Sci; 1993; 53(23):1753-9. PubMed ID: 8246671
[TBL] [Abstract][Full Text] [Related]
16. A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: comparison with central serotonergic neurons.
Stahl SM; Meltzer HY
J Pharmacol Exp Ther; 1978 Apr; 205(1):118-32. PubMed ID: 633077
[TBL] [Abstract][Full Text] [Related]
17. [Uptake and release of C14-dopamine in platelets of normal subjects and in patients with Parkinson's syndrome (author's transl)].
Campanella G; Yamada K; Butterworth R; Barbeau A
Riv Patol Nerv Ment; 1974 Oct; 95(5):653-61. PubMed ID: 4470265
[No Abstract] [Full Text] [Related]
18. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes.
Da Prada M; Pletscher A
Br J Pharmacol; 1968 Nov; 34(3):591-7. PubMed ID: 5726788
[TBL] [Abstract][Full Text] [Related]
19. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
20. The binding of haloperidol to human blood platelets and interactions with 5-hydroxytryptamine and dopamine.
Boullin DJ; Molyneux D; Roach B
Br J Pharmacol; 1978 Jul; 63(3):561-6. PubMed ID: 667500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
